文献速递造血干细胞移植与细胞治疗白血病

抗体介导的慢性移植物抗宿主病通过DBY/HLA II类复合物及诱导移植物抗白血病效应的发病机制

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
PubMed 文献 · Blood · 2023-01-01

本研究分析全国登记数据发现,HLA-DRB1*15:02与女性供者至男性受者移植后男性慢性移植物抗宿主病(cGVHD)易感性相关(HR 1.28,95%CI 1.03-1.58,P=0.025);HLA II类分子可呈递DBY至细胞表面,抗DBY/HLA II类复合物抗体预测cGVHD发生(1年68.8% vs 31.7%,P=0.002),且该复合物见于部分男性白血病细胞,提示其可能为cGVHD和移植物抗白血病效应的共同靶点。

要点

  • HLA-DRB1*15:02与女性供者至男性受者移植后男性cGVHD易感性相关(HR 1.28,95%CI 1.03-1.58,P=0.025)。
  • 抗DBY/HLA II类复合物抗体预测cGVHD发生(1年68.8% vs 31.7%,P=0.002)。
  • DBY与HLA II类分子在cGVHD皮损血管内皮共定位并引发补体依赖的细胞毒作用。

核心结论

  • 血管内皮细胞促进抗体介导的cGVHD,抗DBY/HLA II类复合物抗体可能是cGVHD和移植物抗白血病效应的共同靶点。

研究设计与样本

  • 分析全国登记数据,按供受者性别分层,鉴定与女性供者至男性受者移植后男性cGVHD易感性相关的HLA II类等位基因。

主要发现

  • HLA-DRB1*15:02与女性供者至男性受者移植后男性cGVHD易感性相关(HR 1.28,95%CI 1.03-1.58,P=0.025)。
  • HLA-DRB1*15:02共表达可有效将全长H-Y抗原尤其DBY转运至细胞表面。
  • 抗DBY/HLA II类复合物抗体预测cGVHD发生(1年68.8% vs 31.7%,P=0.002)。
  • HLA II类分子转运和呈递DBY的能力与HLA II类等位基因的cGVHD易感性密切相关。
  • DBY在cGVHD皮损血管内皮与HLA II类分子共定位并引发补体依赖的细胞毒作用,这些复合物也见于部分男性白血病细胞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic graft-versus-host disease (cGVHD) is a multiorgan syndrome with clinical features resembling those of autoimmune diseases. Thus, understanding commonalities in the pathophysiology of cGVHD and autoimmune diseases, such as the presence of disease-risk HLA alleles, is imperative for developing novel therapies against cGVHD. Alloantibodies against H-Y antigens encoded on the Y-chromosome are well-described risk factors for cGVHD in female-to-male transplantation. However, because H-Y antigens generally localize intracellularly in the male reproductive organs, how they emerge at affected organ levels remains elusive. Here, by analyzing nationwide registry data stratified per donor-recipient sex, we identified specific HLA class II alleles that contributed to susceptibility to male cGVHD after transplantation from HLA-identical female siblings (HLA-DRB1∗15:02: hazard ratio, 1.28; 95% confidence interval, 1.03-1.58; P = .025). Coexpression of HLA-DRB1∗15:02 efficiently transported full-length H-Y antigens, especially DBY, to the surface. The presence of alloantibodies against DBY/HLA class II complexes significantly predicted the occurrence of cGVHD (68.8% vs 31.7% at 1 year; P = .002). Notably, the ability of HLA class II molecules to transport and present DBY to alloantibodies was closely associated with the susceptibility of HLA class II alleles to cGVHD. DBY specifically colocalized with HLA class II molecules on the dermal vascular endothelium in cGVHD and provoked complement-dependent cytotoxicity. Moreover, these complexes were observed in some male leukemic cells. Altogether, these findings suggest that vascular endothelial cells facilitate alloantibody-mediated cGVHD and highlight that alloantibodies against DBY/HLA class II complexes could be common targets for cGVHD and a graft-versus-leukemia effect.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Umino K, Morita K, Ikeda T, et al. Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect. Blood. 2023. PMID: 37363859. doi:10.1182/blood.2023019799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。